BANCOLOMBIA S.A.-SPONS ADR (CIB)

US05968L1026 - ADR

33.93  +0.53 (+1.59%)

After market: 33.93 0 (0%)

Fundamental Rating

3

Taking everything into account, CIB scores 3 out of 10 in our fundamental rating. CIB was compared to 412 industry peers in the Banks industry. CIB may be in some trouble as it scores bad on both profitability and health. CIB is valied quite expensively at the moment, while it does show a decent growth rate. Finally CIB also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

CIB had positive earnings in each of the past 5 years.
Of the past 5 years CIB 4 years had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 1.87%, CIB belongs to the best of the industry, outperforming 94.90% of the companies in the same industry.
CIB has a Return On Equity of 16.82%. This is amongst the best in the industry. CIB outperforms 94.17% of its industry peers.
Industry RankSector Rank
ROA 1.87%
ROE 16.82%
ROIC N/A
ROA(3y)1.71%
ROA(5y)1.31%
ROE(3y)15.36%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 19.96%, CIB is not doing good in the industry: 67.48% of the companies in the same industry are doing better.
CIB's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for CIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 19.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y130.09%
PM growth 5Y3.49%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CIB has about the same amount of shares outstanding.
CIB has about the same amout of shares outstanding than it did 5 years ago.
CIB has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of CIB is 2.89, which is a good value as it means it would take CIB, 2.89 years of fcf income to pay off all of its debts.
CIB has a Debt to FCF ratio of 2.89. This is comparable to the rest of the industry: CIB outperforms 46.36% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that CIB is somewhat dependend on debt financing.
CIB's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. CIB is outperformed by 78.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 2.89
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

CIB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.15%.
Measured over the past years, CIB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.14% on average per year.
The Revenue has grown by 26.15% in the past year. This is a very strong growth!
CIB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.14% yearly.
EPS 1Y (TTM)-4.15%
EPS 3Y180.91%
EPS 5Y18.14%
EPS growth Q2Q-13.92%
Revenue 1Y (TTM)26.15%
Revenue growth 3Y22.08%
Revenue growth 5Y14.14%
Revenue growth Q2Q3.95%

3.2 Future

CIB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.12% yearly.
CIB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y-9.23%
EPS Next 2Y-1.52%
EPS Next 3Y1.12%
EPS Next 5YN/A
Revenue Next Year-1.23%
Revenue Next 2Y1.22%
Revenue Next 3Y2.71%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.52%
EPS Next 3Y1.12%

7

5. Dividend

5.1 Amount

CIB has a Yearly Dividend Yield of 10.25%, which is a nice return.
CIB's Dividend Yield is rather good when compared to the industry average which is at 3.78. CIB pays more dividend than 100.00% of the companies in the same industry.
CIB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 10.25%

5.2 History

The dividend of CIB is nicely growing with an annual growth rate of 15.46%!
CIB has been paying a dividend for at least 10 years, so it has a reliable track record.
CIB has decreased its dividend in the last 3 years.
Dividend Growth(5Y)15.46%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

50.67% of the earnings are spent on dividend by CIB. This is a bit on the high side, but may be sustainable.
The dividend of CIB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.67%
EPS Next 2Y-1.52%
EPS Next 3Y1.12%

BANCOLOMBIA S.A.-SPONS ADR

NYSE:CIB (5/3/2024, 7:04:00 PM)

After market: 33.93 0 (0%)

33.93

+0.53 (+1.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.16B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 10.25%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.87%
ROE 16.82%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 19.96%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-4.15%
EPS 3Y180.91%
EPS 5Y
EPS growth Q2Q
EPS Next Y-9.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.15%
Revenue growth 3Y22.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y